These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18078271)

  • 41. Treatment of melanoma brain metastases.
    Goldinger SM; Panje C; Nathan P
    Curr Opin Oncol; 2016 Mar; 28(2):159-65. PubMed ID: 26809015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain metastasis: opportunity for drug development?
    Preusser M; Berghoff AS; Schadendorf D; Lin NU; Stupp R
    Curr Opin Neurol; 2012 Dec; 25(6):786-94. PubMed ID: 23108247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer?
    Addeo R; Caraglia M
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):139-42. PubMed ID: 21342029
    [No Abstract]   [Full Text] [Related]  

  • 44. [Trastuzumab emtansine in the systemic treatment of HER-2-positive breast cancer brain metastases].
    Frenel JS; Bally O; Bourbouloux E; Berton-Rigaud D; Campone M; Bachelot T; Heudel PÉ
    Bull Cancer; 2016 May; 103(5):507-10. PubMed ID: 26992855
    [No Abstract]   [Full Text] [Related]  

  • 45. Chemoprevention for brain metastases.
    Trinh VA; Hwu WJ
    Curr Oncol Rep; 2012 Feb; 14(1):63-9. PubMed ID: 22006097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
    Barnholtz-Sloan JS; Sloan AE; Davis FG; Vigneau FD; Lai P; Sawaya RE
    J Clin Oncol; 2004 Jul; 22(14):2865-72. PubMed ID: 15254054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic therapies for melanoma brain metastases: which drug for whom and when?
    Ramanujam S; Schadendorf D; Long GV
    Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.
    Margolin K; Ernstoff MS; Hamid O; Lawrence D; McDermott D; Puzanov I; Wolchok JD; Clark JI; Sznol M; Logan TF; Richards J; Michener T; Balogh A; Heller KN; Hodi FS
    Lancet Oncol; 2012 May; 13(5):459-65. PubMed ID: 22456429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ipilimumab in patients with melanoma and brain metastases.
    Nieder C
    Lancet Oncol; 2012 Jul; 13(7):e277; author reply e277-8. PubMed ID: 22748259
    [No Abstract]   [Full Text] [Related]  

  • 50. Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma.
    Göring HD; Zierner A; Kröning Y; Trebing D; Kämpgen E; Bröcker EB
    Melanoma Res; 1998 Aug; 8(4):379. PubMed ID: 9764815
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of brain metastases in patients with melanoma.
    Fisher R; Larkin J
    Lancet Oncol; 2012 May; 13(5):434-5. PubMed ID: 22456430
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial).
    Nasu K; Satoh T; Nishio S; Nagai Y; Ito K; Otsuki T; Hongo A; Hirashima Y; Ogura T; Shimada M
    Gynecol Oncol; 2013 Feb; 128(2):198-203. PubMed ID: 23142074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases.
    Patel KR; Shoukat S; Oliver DE; Chowdhary M; Rizzo M; Lawson DH; Khosa F; Liu Y; Khan MK
    Am J Clin Oncol; 2017 Oct; 40(5):444-450. PubMed ID: 26017484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic chemotherapeutic treatment of patients with breast cancer brain metastases.
    Liubota R; Vereshchako R; Anikusko M; Liubota I; Vakulenko G
    Exp Oncol; 2021 Jun; 43(2):180-184. PubMed ID: 34190516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival after brain metastases from breast cancer in the trastuzumab era.
    Kirsch DG; Ledezma CJ; Mathews CS; Bhan AK; Ancukiewicz M; Hochberg FH; Loeffler JS
    J Clin Oncol; 2005 Mar; 23(9):2114-6; author reply 2116-7. PubMed ID: 15774813
    [No Abstract]   [Full Text] [Related]  

  • 56. A rare case of breast sarcoma brain metastases.
    Esquerdo G; Llorca C; Cervera JM; Briceño H
    J Neurooncol; 2005 Apr; 72(2):123. PubMed ID: 15925991
    [No Abstract]   [Full Text] [Related]  

  • 57. Chemotherapy for brain metastases due to lung cancer and melanoma.
    Chamberlain MC
    Cancer Treat Res; 2007; 136():199-213. PubMed ID: 18078272
    [No Abstract]   [Full Text] [Related]  

  • 58. Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).
    Hill GJ; Ruess R; Berris R; Philpott GW; Parkin P
    Ann Surg; 1974 Aug; 180(2):167-74. PubMed ID: 4601984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab.
    Colozza M; Minenza E; Gori S; Fenocchio D; Paolucci C; Aristei C; Floridi P
    Cancer Chemother Pharmacol; 2009 May; 63(6):1157-9. PubMed ID: 18987856
    [No Abstract]   [Full Text] [Related]  

  • 60. A review of the classification of malignant melanoma.
    Mihm MC; Lopansri S
    J Dermatol; 1979 Jun; 6(3):131-42. PubMed ID: 393742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.